Join Accelera at the upcoming SOT!




49th Annual Meeting and Tox Expo
Salt Lake City, Utah, USA
March 7-11, 2010


Stop by BOOTH # 509
to have an ESPRESSO
with the ACCELERA team



  We are proud to announce the following

        EXHIBITOR HOSTED SESSION

        March 9 at 9:45 (ROOM 155C)

"Preclinical Anticancer Drug Development: Shifting Challenges"

9:45   Welcome, Introductions and
           Market Overview
         Michael Prosser, Head of Business
         Development, Accelera Srl

9:50   Anticancer Candidate Selection
         Pietro Grossi, Senior Director 
         DMPK/ART, Accelera Srl

10:05  IND Packages and
            Risk Assessment
          Paolo Colombo, Director of ADMET
          Accelera Srl

10:20  Regulatory Perspective:
            The Impact of ICH S9
          Marco Brughera, Vice President
          Accelera Srl

10:30  Combination Treatments:
            Preclinical Challenges
          Klaus Krauser, Vice President,
          Global Head Toxicology,
          Merck Serono R&D

10:40  Q&A
          All

             REFRESHMENTS WILL BE SERVED!

If you would like to schedule a meeting with an Accelera representative at the SOT, or if you need more information on services we provide, please visit our website at www.accelera.org or contact us at info@accelera.org

For further information regarding SOT:
http://www.toxicology.org/ai/meet/am2010/



Print
Request for information